Connection

Konstantinos Syrigos to Aged

Back to Details
This is a "connection" page, showing publications Konstantinos Syrigos has written about Aged.
Konstantinos Syrigos
Connection Strength
0.181
Aged
  1. Statin use and mortality in COVID-19 patients: Updated systematic review and meta-analysis. Atherosclerosis. 2021 08; 330:114-121.
    View in: PubMed
    Score: 0.017
  2. Venous thromboembolism in COVID-19: A systematic review and meta-analysis. Vasc Med. 2021 08; 26(4):415-425.
    View in: PubMed
    Score: 0.017
  3. Beneficial Effects of Intermediate Dosage of Anticoagulation Treatment on the Prognosis of Hospitalized COVID-19 Patients: The ETHRA Study. In Vivo. 2021 Jan-Feb; 35(1):653-661.
    View in: PubMed
    Score: 0.016
  4. Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer-Associated Thrombosis: The Observational ROADMAP-CAT Study. Oncologist. 2018 11; 23(11):1372-1381.
    View in: PubMed
    Score: 0.014
  5. Epidemiological Characteristics, EGFR Status and Management Patterns of Advanced Non-small Cell Lung Cancer Patients: The Greek REASON Observational Registry Study. Anticancer Res. 2018 Jun; 38(6):3735-3744.
    View in: PubMed
    Score: 0.014
  6. Khorana Score: ?ew Predictor of Early Mortality in Patients With Lung Adenocarcinoma. Clin Appl Thromb Hemost. 2018 Nov; 24(8):1347-1351.
    View in: PubMed
    Score: 0.014
  7. Chromosome 7 Multiplication in EGFR-positive Lung Carcinomas Based on Tissue Microarray Analysis. In Vivo. 2017 Jul-Aug; 31(4):641-648.
    View in: PubMed
    Score: 0.013
  8. Thermal ablation may improve outcomes in patients with colorectal liver metastasis: a case-control study. J BUON. 2017 May-Jun; 22(3):673-678.
    View in: PubMed
    Score: 0.013
  9. Pulmonary hypertension after pneumonectomy for lung cancer. Asian Cardiovasc Thorac Ann. 2014 Nov; 22(9):1072-9.
    View in: PubMed
    Score: 0.010
  10. An open label trial of anakinra to prevent respiratory failure in COVID-19. Elife. 2021 03 08; 10.
    View in: PubMed
    Score: 0.004
  11. Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial. JAMA Netw Open. 2020 06 01; 3(6):e2013136.
    View in: PubMed
    Score: 0.004
  12. Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer. N Engl J Med. 2019 11 21; 381(21):2020-2031.
    View in: PubMed
    Score: 0.004
  13. A phase II study of nab-paclitaxel and carboplatin chemotherapy plus necitumumab in the first-line treatment of patients with stage IV squamous non-small cell lung cancer. Lung Cancer. 2019 10; 136:52-56.
    View in: PubMed
    Score: 0.004
  14. Healthcare resource utilization and associated cost analysis of the PROCLAIM study in patients with stage III non-small-cell lung cancer. Curr Med Res Opin. 2019 10; 35(10):1761-1767.
    View in: PubMed
    Score: 0.004
  15. Immune Marker Profiling and Programmed Death Ligand 1 Expression Across NSCLC Mutations. J Thorac Oncol. 2018 12; 13(12):1884-1896.
    View in: PubMed
    Score: 0.004
  16. Association of ERBB Mutations With Clinical Outcomes of Afatinib- or Erlotinib-Treated Patients With Lung Squamous Cell Carcinoma: Secondary Analysis of the LUX-Lung 8 Randomized Clinical Trial. JAMA Oncol. 2018 09 01; 4(9):1189-1197.
    View in: PubMed
    Score: 0.003
  17. Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping. Med Oncol. 2018 May 31; 35(7):101.
    View in: PubMed
    Score: 0.003
  18. The Autotaxin-Lysophosphatidic Acid Axis Promotes Lung Carcinogenesis. Cancer Res. 2018 07 01; 78(13):3634-3644.
    View in: PubMed
    Score: 0.003
  19. Spatially Resolved and Quantitative Analysis of VISTA/PD-1H as a Novel Immunotherapy Target in Human Non-Small Cell Lung Cancer. Clin Cancer Res. 2018 04 01; 24(7):1562-1573.
    View in: PubMed
    Score: 0.003
  20. Lapatinib with whole brain radiotherapy in patients with brain metastases from breast and non-small cell lung cancer: a phase II study of the Hellenic Cooperative Oncology Group (HeCOG). J Neurooncol. 2017 Sep; 134(2):443-451.
    View in: PubMed
    Score: 0.003
  21. B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes. Clin Cancer Res. 2017 Sep 01; 23(17):5202-5209.
    View in: PubMed
    Score: 0.003
  22. Evaluation of the VeriStrat® serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lung 8 study. Lung Cancer. 2017 07; 109:101-108.
    View in: PubMed
    Score: 0.003
  23. Cabazitaxel Versus Topotecan in Patients with Small-Cell Lung Cancer with Progressive Disease During or After First-Line Platinum-Based Chemotherapy. J Thorac Oncol. 2015 Aug; 10(8):1221-8.
    View in: PubMed
    Score: 0.003
  24. Programmed death ligand-1 expression in non-small cell lung cancer. Lab Invest. 2014 Jan; 94(1):107-16.
    View in: PubMed
    Score: 0.003
  25. High expression of mammalian target of rapamycin is associated with better outcome for patients with early stage lung adenocarcinoma. Clin Cancer Res. 2009 Jun 15; 15(12):4157-64.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.